Report cover image

Neuropathy Pain Treatment Market by Pain Type (Coccydynia, Entrapment Neuropathy, Foot Pain), Indication (Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Spinal Stenosis), Treatment, Distribution Channel, End-User - Global Forecast 2024-2

Publisher 360iResearch
Published Jan 15, 2024
Length 190 Pages
SKU # IRE18446470

Description

Neuropathy Pain Treatment Market by Pain Type (Coccydynia, Entrapment Neuropathy, Foot Pain), Indication (Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Spinal Stenosis), Treatment, Distribution Channel, End-User - Global Forecast 2024-2030


The Neuropathy Pain Treatment Market size was estimated at USD 7.74 billion in 2023 and expected to reach USD 8.59 billion in 2024, at a CAGR 11.53% to reach USD 16.61 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neuropathy Pain Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neuropathy Pain Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neuropathy Pain Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Assertio Holdings, Inc., Astellas Pharma Inc., AstraZeneca PLC, Aurobindo Pharma Limited, Baxter International Inc., Biogen Inc., Bristol Myers Squibb Company, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson Services, Inc., Novartis AG, Pfizer Inc., and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Neuropathy Pain Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Pain Type

Coccydynia

Entrapment Neuropathy

Foot Pain

Peripheral Neuropathy

Phantom Limb Neuropathy

Post Herpetic Neuralgia (PHN)

Post Traumatic Neuropathy

Trigeminal Neuralgia
Indication

Chemotherapy-Induced Peripheral Neuropathy

Diabetic Neuropathy

Spinal Stenosis
Treatment

Drugs
Antidepressant Drugs Type

Serotonin Noradrenaline

Tricyclic Antidepressants
Medication Type
Multimodal Therapy
NSAIDs Type

Ibuprofen

Naproxen

Therapy
Distribution Channel

Online Pharmacies

Retail Pharmacies & Drug Stores
End-User

Clinics

Hospitals
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Neuropathy Pain Treatment Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neuropathy Pain Treatment Market?
3. What are the technology trends and regulatory frameworks in the Neuropathy Pain Treatment Market?
4. What is the market share of the leading vendors in the Neuropathy Pain Treatment Market?
5. Which modes and strategic moves are suitable for entering the Neuropathy Pain Treatment Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

190 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Neuropathy Pain Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in neuropathic pain among population
5.1.1.2. Increasing global healthcare expenditure
5.1.1.3. Growing number of neuropathic pain relievers and over-the-counter products
5.1.2. Restraints
5.1.2.1. Limited awareness of available treatment options
5.1.3. Opportunities
5.1.3.1. Introduction of novel pain treatment alternatives
5.1.3.2. Programs and initiatives focusing on palliative care
5.1.4. Challenges
5.1.4.1. Complexity in identifying the treatment suitable for neuropathic pains in a patient
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Neuropathy Pain Treatment Market, by Pain Type
6.1. Introduction
6.2. Coccydynia
6.3. Entrapment Neuropathy
6.4. Foot Pain
6.5. Peripheral Neuropathy
6.6. Phantom Limb Neuropathy
6.7. Post Herpetic Neuralgia (PHN)
6.8. Post Traumatic Neuropathy
6.9. Trigeminal Neuralgia
7. Neuropathy Pain Treatment Market, by Indication
7.1. Introduction
7.2. Chemotherapy-Induced Peripheral Neuropathy
7.3. Diabetic Neuropathy
7.4. Spinal Stenosis
8. Neuropathy Pain Treatment Market, by Treatment
8.1. Introduction
8.2. Drugs
8.3.1. Antidepressant Drugs Type
8.3.2.1. Serotonin Noradrenaline
8.3.2.2. Tricyclic Antidepressants
8.3.2. Medication Type
8.3.3. Multimodal Therapy
8.3.4. NSAIDs Type
8.3.5.1. Ibuprofen
8.3.5.2. Naproxen
8.3. Therapy
9. Neuropathy Pain Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Online Pharmacies
9.3. Retail Pharmacies & Drug Stores
10. Neuropathy Pain Treatment Market, by End-User
10.1. Introduction
10.2. Clinics
10.3. Hospitals
11. Americas Neuropathy Pain Treatment Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Neuropathy Pain Treatment Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Neuropathy Pain Treatment Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. Assertio Holdings, Inc.
15.1.3. Astellas Pharma Inc.
15.1.4. AstraZeneca PLC
15.1.5. Aurobindo Pharma Limited
15.1.6. Baxter International Inc.
15.1.7. Biogen Inc.
15.1.8. Bristol Myers Squibb Company
15.1.9. Dr. Reddy’s Laboratories Ltd.
15.1.10. Eli Lilly and Company
15.1.11. GlaxoSmithKline PLC
15.1.12. Johnson and Johnson Services, Inc.
15.1.13. Novartis AG
15.1.14. Pfizer Inc.
15.1.15. Sun Pharmaceutical Industries Limited
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. NEUROPATHY PAIN TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. NEUROPATHY PAIN TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NEUROPATHY PAIN TREATMENT MARKET DYNAMICS
FIGURE 7. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2023 VS 2030 (%)
FIGURE 8. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 12. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. NEUROPATHY PAIN TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. NEUROPATHY PAIN TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us